An important scientific study published in The Lancet shows the strong public health impact of deploying molecular diagnostics closer to the people.

Study proves strong impact of taking molecular TB diagnostics closer to the people. By SHOBHA SHUKLA, BOBBY RAMAKANT ...

Investing.com -- bioAffinity Technologies Inc (NASDAQ:BIAF) stock surged 14% on Thursday after the biotechnology company announced it received a notification of allowance from the United States Patent ...

Affinity Technologies, Inc. ( ($BIAF) ) has issued an update. On October 16, 2025, bioAffinity Technologies, Inc. announced it received a ...

Co-Diagnostics (CODX) announced the development of a proprietary sample preparation instrument designed to streamline and simplify the workflow ...

The US Patent and Trademark Office will issue BIAF a new patent on its flow cytometry+AI platform that detects lung cancer as ...

Chronic cough, breathlessness or pollution exposure may signal underlying lung disease. Here's when you should consider a ...

Scientists have developed a new device that may help identify tuberculosis DNA from exhaled air -- known as aerosols.

Scientists have developed a new device that may help identify tuberculosis DNA from exhaled air -- known as ...

Researchers at Karolinska Institutet, in collaboration with colleagues in South Africa, have investigated whether ...

Sales of bioAffinity's CyPath® Lung test for lung cancer reached a new high in Q3 2025, representing a 95% increase over the ...